Testing Oral Decitabine and Cedazuridine (ASTX727) in Combination With Venetoclax for Higher-Risk Acute Myeloid Leukemia Patients
Clinical trial NCT04817241 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04817241
- Sponsor
- National Cancer Institute (NCI)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-10
- Primary completion
- 2025-06-06
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.